ArticleCancer research and treatment2022

Clinical Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients with Liver Metastases: A Network Meta-Analysis of Nine Randomized Controlled Trials.

Qing Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.